Healthcare - Biotechnology - NASDAQ - AU
$ 3.24
-4.42 %
$ 581 M
Market Cap
-1.17
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
474.19%
EBIT
Estimate
--32.41%
Net Income
Estimate
63.05%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Opthea Limited
OPT has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart OPT
EBIT FORECAST
EBIT Forecast Chart OPT
NET INCOME FORECAST
Net Income Chart OPT